The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemoradiation with or without nimotuzumab in locally advanced esophageal cancer (LAEC): A randomized phase II study (NICE trial).
Gilberto Castro
No relevant relationships to disclose
Nils G SKARE
No relevant relationships to disclose
Carlos J C Andrade
No relevant relationships to disclose
J.G.M. Segalla
No relevant relationships to disclose
Sergio Jobim De Azevedo
No relevant relationships to disclose
Ismael D C G Silva
No relevant relationships to disclose
Fauze Maluf Filho
No relevant relationships to disclose
Lucienne Pereira Del Grossi Neusquen
Employment or Leadership Position - Eurofarma Laboratorios S.A.
Cassiano Ricardo de Oliveira Berto
Employment or Leadership Position - Eurofarma Laboratorios S.A.